Prologue Journal

Johnson & Johnson to Acquire Amrbx for $2B

• prologu5
• 01/08/202401/08/2024

Wall Street Journal

Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal.

https://www.wsj.com/articles/johnson-johnson-to-acquire-cancer-treatment-developer-amrbx-for-2b-f7fbafea